Pfizer Asks F.D.A. to Clear 2 Vaccine Doses for Young Children as a Start
The Food and Drug Administration asked to review Pfizer’s data on two doses now, while the company continues to assess whether three doses would be more effective.
The Food and Drug Administration asked to review Pfizer’s data on two doses now, while the company continues to assess whether three doses would be more effective.